Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

The InDx CMC Implant. A new treatment for thumb base joint arthritis.

Project description

A thumb implant

Thumb base joint arthritis is a common and disabling condition. It is estimated to affect over 30 million people across the EU causing ongoing hand pain on simple activities of daily living. Funded by the European Innovation Council, the InDx CMC Implant project is developing the first solution to fully recreate the natural motions of the thumb, while decreasing pain and restoring hand function. Following successful preclinical evaluation, the implant is now undergoing clinical trials. The project will enable regulatory clearance of the implant, making it available to those affected, relieving pain and disability.

Objective

The InDx CMC Implant is for the treatment of thumb base joint arthritis. It is the first evidence-based, surgeon-led innovation, implant solution for this major clinical problem. The potential market is estimated at over €700M per year.
The implant meets a major unmet clinical need for an ageing EU population.
The implant re-creates the natural joint biomechanics to give a more reliable and clinically superior outcome for patients. This disruptive technology can change the treatment landscape for this condition. The implant provides an exciting new treatment option for an under-served population. It has been shown to eliminate pain and restore full joint mobility.
The InDx Implant is smarter, safer, and simpler to insert than any current treatment options.
The InDx Implant is patented, with a clear pathway to regulatory clearance in the EU and US.
The company is led by a physician-innovator and is supported by medical device industry veterans and world-leading hand surgeons.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-ACCELERATOR-01

See all projects funded under this call

Coordinator

LOCI ORTHOPAEDICS LIMITED
Net EU contribution
€ 2 500 000,00
Address
UNIT 4 BUSINESS INNOVATION CENTRE NATIONAL UNIVERSITY OF IRELAND
H91 H2Y0 GALWAY
Ireland
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 3 658 337,50